A placebo-controlled trial showed that use of the antidepressant mirtazapine in routine clinical practice reduced methamphetamine use in adults with methamphetamine use disorder. There were no ...
There are no approved medications for methamphetamine use disorder, but phase 3 trial results suggest the generic ...
Methamphetamine – more commonly known as meth, crystal or ice – is a highly addictive, stimulant drug. An estimated 7.4 ...
(THE CONVERSATION) Methamphetamine doesn’t just spike levels of the pleasure-inducing hormone dopamine in the reward pathways of the brain – it also provokes damaging brain inflammation through ...
A phase 2 trial evaluating CS-1103 in participants with methamphetamine use disorder is expected to begin in the first quarter of 2026. The Food and Drug Administration (FDA) has granted Fast Track ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results